Foghorn Therapeutics cuts workforce about 40% in reorganization to extend cash runway into H2 2029
Bitget2026/10/01 11:03- Foghorn launched a corporate reorganization to refocus on wholly owned programs following the decision to stop advancing FHD-909.
- Workforce to shrink about 40% as operating structure is realigned to prioritize proprietary pipeline development.
- Cash runway expected to extend into the second half of 2029 under the new plan.
- Collaboration with Lilly to end, with no further work planned on FHD-909 or the selective SMARCA2 degrader program.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

Grayscale Warns Bitcoin’s Lower Volatility Doesn’t Mean Lower Risk

CoreWeave downplays Jensen Huang's departure, says Nvidia remains a key partner
CoreWeave’s Vice President of Strategy stated that the company will continue its partnership with Nvidia, with hundreds or even thousands of layers of business collaboration between the two sides. Nvidia is a vast institution, not reliant on a single individual for its operations. However, this statement failed to boost market sentiment, and CoreWeave’s stock is currently down more than 5% during intraday trading.

